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ISSUES IN-DEPTH

Advancing understanding of drug
addiction and treatment
by Roxanne Greitz Miller

While most school districts utilize a drug abuse resistance curriculum, as science teachers, it is our responsibility to understand the science behind drug addiction in order to most effectively educate our students
against drug abuse. In the last two decades, increases
in scientific technology have permitted significant discoveries surrounding the neurobiology, genetic components, and treatment of drug addiction. This article
addresses the latest scientific knowledge about drug
addiction and treatment with information that can be
used in the middle school setting, focusing on cocaine
addiction to illustrate the points discussed.

What is drug addiction?

Most scientists now consider drug addiction a biomedical rather than a psychological condition, or a failure
of will, as many laypersons still believe. The American
Medical Association, American Psychiatric Association,
and other organizations now describe drug addiction
as a brain disease that causes an uncontrollable, compulsive drug craving, seeking, and use even in the face
of negative health and social consequences. Addiction
must be distinguished from the term dependence, which
refers to whether physical or psychological withdrawal
symptoms will occur if drug use is discontinued. Certain drugs, such as heroin and alcohol, create physical
dependence, while other drugs, such as cocaine, produce very few symptoms of physical dependence and
are therefore referred to as primarily creating psychological dependence.
Drug education programs of the past, particularly
in the 1970s and 1980s, highlighted physical versus
psychological addiction, an emphasis that is now seen
as archaic in the drug treatment world. Addiction can
occur whether the drug used creates physical or psychological dependence, and the compulsion to use the
two classes of drugs can be equal. Addiction causes
physical changes in the brain, regardless of whether
the drug used causes physical withdrawal symptoms
upon discontinuance, and it is these changes in brain
function that result in the addict’s compulsion to continue drug use.
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An analogy used to illustrate how addiction occurs
is that “after a certain amount of a drug is consumed,
it is as if a switch in the brain is flipped from normal
to addict” (Leshner 2001). The amount of drugs that
must be consumed to cause these brain changes is different for everyone, which helps to explain why some
people become addicted after low to moderate drug use
when others can use higher levels of drugs or use them
for longer periods of time and not show symptoms of
addiction (Leshner 2001). Specifically, in the case of
cocaine and related stimulant drugs (such as crystal
methamphetamine), some addicts report that craving
began after as few as one to two incidents of use.
Recent scientific evidence suggests that between
50–70% of the variability in susceptibility to becoming
addicted is due to genetic factors, while environmental
and biological factors also play a role (Leshner 2001).
Therefore, while it is accurate to state that addiction
can run in families due to their shared genetic makeup,
an absence of addicts in a family does not remove the
possibility of genetic predisposition to addiction. This
is why the phrase “be smart, don’t start” represents
the most effective way to prevent addiction. Abstaining
entirely from drug use will prevent addiction from occurring, regardless of whether or not a genetic predisposition to addiction is present.
For those who do not heed this advice and become
addicted, even if their brain function is returned to
normal after treatment, it is possible that the psycho-
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logical effects of addiction, including the compulsion
to use drugs, can continue for years after drug use has
stopped. Stressing these points—that one cannot predict when addiction will develop, that one can carry a
genetic predisposition to addiction without knowing it,
that addiction can develop even after only low levels of
drug use, and that the effects of addiction can last long
after treatment—when educating students strengthens
the argument that prevention and abstinence from all
drug use are the most effective treatment.
While it is true that a drug user initially voluntarily
chooses to engage in drug use, the neurobiology research contradicts the notion that the user can simply “decide” to quit. Due to the changes in the brain
over time, the addict loses control over what was
once voluntary drug use, and that behavior becomes
compulsive and truly uncontrollable, much like other
behavioral expressions of brain disease. For example,
Parkinson’s patients cannot control their trembling,
nor can schizophrenics control their hallucinations.
It is important for students to understand that due to
changes in the brain, outside help and medical treatment are almost always necessary to break addiction.
While stories of individuals who are able to break their
addiction without outside help are indeed true, it is
estimated that less than 1 in 10 former addicts successfully quits without formal treatment. When compared
to the total number of current and former addicts and
those who have died from drug use, it becomes readily
apparent how few drug addicts recover without formal
treatment. Understanding the extreme difficulty in
quitting without formal treatment helps students to
understand why family members are so often unsuccessful in changing the behavior of their loved ones
who struggle with addiction, no matter how hard they
try or how much they are loved by the addict.

What causes the high?

The sense of a drug “high” comes from the effect of the
drug on the process of neurotransmission in the brain.
Most science teachers are familiar with information in
the brain being delivered from one neuron to another
in a nerve pathway using chemicals called neurotransmitters. The neurotransmitters carry the signal from
the sending neuron to the receiving neuron across the
synapse, the space between neurons. Common neurotransmitters in the brain include dopamine, serotonin,
gamma-aminobutyric acid (GABA), and acetylcholine.
Dopamine, the specific neurotransmitter affected by
cocaine use, is directly or indirectly affected by virtually every addictive substance. Dopamine is released in
two ways: (1) in constant, low levels (called tonic levels)

that aid in proper brain and motor function, and (2) in
higher levels during a person’s engagement in activities
that activate the reward pathway of the brain, such as
eating, sex, or addictive drug use.
Drugs of abuse alter normal neurotransmission by
increasing the level or effect of the neurotransmitter
in the brain. This can be accomplished by increasing
the production or release of neurotransmitters, by enhancing the reception of the neurotransmitter at the
receiving neuron, or by preventing neurotransmitter
reuptake in/return to the sending neuron from which it
was released. No matter the exact mechanism, the drug
high is a result of increasing the neurotransmitter’s effect, causing an increased stimulus of the receiving
neurons. This state of overstimulation of the receiving
neurons by the neurotransmitters (specifically, dopamine) causes the feelings of euphoria and satisfaction
reported by drug users.
When dopamine is released by the sending neuron
to the receiving one, it binds to dopamine receptors on
the receiving neuron’s surface. After the signal is sent,
dopamine is transported back to the sending neuron by
a specialized protein, the dopamine transporter. Cocaine
increases dopamine levels by binding to the dopamine
transporters, thus preventing dopamine’s reuptake by
the sending neurons and thereby causing a buildup of
dopamine in the synapse. This buildup floods the dopamine receptors on the receiving neuron. It is this excess of dopamine in the synapse that causes excessive
stimulation of the receiving neurons and the euphoria
associated with cocaine use.

What treatments are possible?

Historically, psychosocial intervention (counseling) has
been used to help addicts fight their drug addictions.
Examples include the counseling groups sponsored
by organizations such as Alcoholics Anonymous and
Narcotics Anonymous, as well as more individualized
inpatient and outpatient counseling programs.
Medical intervention for drug addiction is often combined with psychosocial intervention. All the current
medical therapies work by either causing severe negative side effects if the drug of abuse is used, or by substituting a drug that acts on the same receptors as the
drug of abuse and therefore allows the drug addict to
engage more effectively in psychosocial therapy without constant craving and compulsion to use drugs. For
example, Antabuse is a drug commonly prescribed to
alcohol-dependent patients; nausea and vomiting occur
if alcohol is consumed while taking Antabuse. The nicotine patch, which is actually a source of nicotine and
not another type of drug, acts exactly the same way as

F e b r u a r y 2 0 09

15

ISSUES IN-DEPTH
tobacco on nicotine receptors. The idea behind its use
is that the patch satisfies the addict’s nicotine craving
while removing the psychological and social cues that
reinforce smoking behavior, and decreases the nicotine
dosage over time while permitting addicts to engage in
psychosocial therapy and ultimately wean themselves
from the need for nicotine. Unlike the nicotine patch,
methadone, which is used in heroin addiction therapy,
is an example of a drug that is similar to the drug of
abuse but is not the same chemical compound. A problem with nearly all treatments that substitute another
drug for the drug of abuse is that the substitute itself
has an approximately equivalent addictive liability if
misused; meaning, it is possible to become addicted to
the treatment.
Cocaine addiction, until recently, has shown to be
highly resistant to medical treatment. The mechanism
of cocaine addiction via its effect on dopamine levels has
been known for over a decade, but medical treatments
aimed at affecting the dopamine receptors have generally been unsuccessful due to the fact that the dopamine
pathway is intricately linked to mood, motor control, and
proper mental functioning (recall the examples of Parkinson’s disease and schizophrenia mentioned above, which
result from malfunctions of the dopamine neurotransmitter systems). Blocking the reception of dopamine means
that not only is the reward-pathway release of dopamine
blocked as a result of drug use, but the normal (tonic)
level of dopamine the body needs to function properly
also cannot be maintained. Therefore, drug addiction
therapies that block the dopamine receptors have often
been either unsuccessful at halting addiction or have
caused undesirable side effects in patients.
Experimental therapies aimed instead at preventing
the release of dopamine during excitation of the reward
pathway are providing promise in treating cocaine addiction. Some of these therapies have capitalized on using
the neurotransmitter GABA, which inhibits dopamine’s
release. GABA regulates the overall excitability of the
human brain. If dopamine can be considered the gas
pedal of a car, GABA is the brake (Lemonick 2007).
When GABA is released, it blocks dopamine release via
the reward pathway, while still allowing for tonic release,
and thereby keeps the neurons in a normal, balanced
state. The reasoning for this GABA-based approach to
drug addiction therapy is that if reward-activated dopamine release can be inhibited, the excessive levels of
dopamine flooding the synapses will be avoided, thus
eliminating the high experienced during cocaine use, but
normal tonic functioning will still be preserved.
Examples of GABA-active drugs include tranquilizers
and antiseizure medications. Among the most promis-
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ing of these in fighting cocaine addiction is vigabatrin
(gamma-vinyl GABA), which is currently being tested
across the United States at multiple treatment centers
(ClinicalTrials.gov 2008). Vigabatrin is a drug used outside of the United States to treat epilepsy. It is unique
among the GABA-active drugs because it prevents the
breakdown of GABA; therefore, when a neuron receives
the signal to release GABA there is a vast storehouse of
GABA available, far more than would normally be present. The end result of this increased amount of available
GABA is that reward-pathway-dopamine release is highly
inhibited, which prevents the usual craving for cocaine
and the high and feelings of euphoria even if cocaine is
still used. In essence, vigabatrin combats the excitability
of the neurons normally affected by cocaine and keeps
the addict’s craving and psychological compulsion to use
cocaine in check, even if the addict falls off the wagon, engaging in drug use during psychosocial treatment. This
is highly important for addicts who do not check into a
residential treatment center and instead opt to engage in
outpatient therapy, where the same external stimuli and
outside stresses and pressures to use cocaine are present. Vigabatrin should not be viewed as a cure for cocaine
addiction; its goal is to decrease or remove the craving
and high associated with cocaine in order to make psychological treatment of addiction more effective.
Interestingly, recent research has shown that virtually
all addictive substances activate this dopamine neurochemical pathway, and it is this neurochemical pathway
that is responsible for sending the “that feels good” signal when an addictive substance is consumed. Dr. Frank
Vocci, director of pharmacotherapies at the National
Institute of Drug Abuse, was quoted in Time magazine
regarding vigabatrin, saying optimistically, “If it works, it
will probably work on all addictions” (Lemonick 2007). It
is expected that results from the clinical trials on vigabatrin will be available in 2009, along with an examination
of any side effects and potential dangers of treatment.

Final words

When discussing drugs and addiction with students,
there are two primary purposes: (1) preventing use,
abuse, and thereby possible addiction in students, now
or in the future, and (2) helping students to understand
addiction so that they can understand the behavior of
others and know the options for treatment. There are
still many people—youth and adults—who believe not
only that addiction is purely psychological and can be
halted at will, but also that because addiction begins with
a voluntary act, it does not deserve to be classified as a
disease. Thus, discussions of addiction can be emotional
and heated, and as teachers we need to be prepared with
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scientific evidence to support any claim we might make
or concept we might teach. While it is true addiction
starts with a voluntary act, the complex neurochemical
cascade that follows this voluntary act is what makes addiction a disease rather than a conscious choice.
While focusing on drug avoidance and decision-making strategies is highly important in aiding students
to abstain from drug use, early adolescents in middle
grades are more able than their younger counterparts
to grasp the scientific mechanisms of drug action and
to understand the genetic predisposition that some individuals have to addiction. If we employ a total approach
to drug education in our curricula, incorporating up-todate information on the psychological, scientific, and
social underpinnings of drug use and addiction, we can
aspire to be even more effective than we have been in
the past at helping our students live healthy lives.
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